Literature DB >> 32602966

Effect of combined physical training on cognitive function in people with epilepsy: Results from a randomized controlled trial.

Natan Feter1,2, Ricardo Alt2, César A Häfele2, Marcelo C da Silva2, Airton J Rombaldi2.   

Abstract

OBJECTIVE: To examine the effect of 12-week exercise program on cognitive function in people with epilepsy.
METHODS: Twenty-one physically inactive subjects were randomized into two groups: the exercise group (EG) or the control group (CG). EG performed 12 weeks of combined physical training. CG was advised to maintain usual daily activities. EG received a structured, individually supervised exercise program with two 60-minute sessions per week. Each session included warmup (5-minutes), aerobic (15-20 minutes at 14-17 on Borg scale), strength (2-3 sets, 10-15 repetitions), and 5-minute active stretches. Sociodemographic characteristics, clinical information, memory (Digit Span Test [DST]), executive function (Trail Making Test [TMT] A and B), Stroop Color and Word Test, a verbal fluency task, global cognitive function (Montreal Cognitive Assessment [MoCA]), anthropometric measurements (weight, height, and hip and waist circumferences), cardiorespiratory fitness (maximal oxygen consumption [VO2 max]), and strength (dynamometer) were measured at baseline and after the 12-week intervention.
RESULTS: Exercise decreased time spent on TMT-A from baseline to postintervention (difference = -7.9 seconds, 95% confidence interval [CI] = -14.5 to -1.3, P = .023). EG improved total number of words on the verbal fluency task after intervention (difference = 8.1 words, 95% CI = 3.0 to 13.2, P = .002). EG also improved the score on MoCA at 1.7 (95% CI = 0.1 to 3.3, P = .043) points. We observed a 22.4% (95% CI = 13.1 to 31.6, P = .021) improvement in executive function in EG. No effect of group, time, or group × time was observed on any other cognitive test. Changes in VO2 max were negatively associated with changes in performance on DST (r = -.445, P = .049) and overall memory score (r = -.544, P = .042). SIGNIFICANCE: This randomized controlled trial provided the first evidence that combined physical training improves executive function in adults with epilepsy, showing main improvements in attention and language tasks. Physical exercise should be encouraged for people with epilepsy to reduce the burden on cognitive function associated with this disease.
© 2020 International League Against Epilepsy.

Entities:  

Keywords:  cognition; epilepsy; exercise; randomized controlled trial

Mesh:

Substances:

Year:  2020        PMID: 32602966     DOI: 10.1111/epi.16588

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

Review 1.  Neurobehavioural comorbidities of epilepsy: towards a network-based precision taxonomy.

Authors:  Bruce P Hermann; Aaron F Struck; Robyn M Busch; Anny Reyes; Erik Kaestner; Carrie R McDonald
Journal:  Nat Rev Neurol       Date:  2021-09-22       Impact factor: 44.711

Review 2.  The Contribution of Physical Exercise to Brain Resilience.

Authors:  Ricardo Mario Arida; Lavinia Teixeira-Machado
Journal:  Front Behav Neurosci       Date:  2021-01-20       Impact factor: 3.558

3.  Application of Unsupervised Transfer Technique Based on Deep Learning Model in Physical Training.

Authors:  Quanbin Zhao; Hanqi Wang
Journal:  Comput Intell Neurosci       Date:  2022-04-14

4.  Considering social determinants of health in the relationship between physical activity and exercise engagement and cognitive impairment among persons with epilepsy.

Authors:  Barbara Hansen; Jane B Allendorfer
Journal:  Front Rehabil Sci       Date:  2022-07-26

5.  The Potential Role of Previous Physical Exercise Program to Reduce Seizure Susceptibility: A Systematic Review and Meta-Analysis of Animal Studies.

Authors:  Ricardo Mario Arida; Adrielle Andrade Passos; Alexandre Lebedev Graciani; João Angelo Ferres Brogin; Mayara de Almeida Lima Ribeiro; Jean Faber; Robson Campos Gutierre; Lavinia Teixeira-Machado
Journal:  Front Neurol       Date:  2021-12-10       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.